Gastric motility in soluble guanylate cyclase α1 knock-out mice

Journal of Physiology

Volumn 584, Issue 3, 2007, Pages 907-920

  Vanneste, Gwen ^a   Dhaese, Ingeborg ^a   Sips, Patrick ^b,c   Buys, Emmanuel ^b,c,d   Brouckaert, Peter ^b,c   Lefebvre, Romain A ^a  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; 8 BROMO CYCLIC GMP; CYCLIC GMP; GUANYLATE CYCLASE; LYASE; NITRIC OXIDE; SOLUBLE GUANYLATE CYCLASE ALPHA1; SOLUBLE GUANYLATE CYCLASE ALPHA1BETA1; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; CARBACHOL; MESSENGER RNA; PROSTAGLANDIN F2 ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC FIELD; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NITRERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SMOOTH MUSCLE RELAXATION; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH MUSCLE; EXON; GENE; GENE EXPRESSION; MULTIFIDUS MUSCLE; MUSCLE TONE; REAL TIME POLYMERASE CHAIN REACTION; SOLUBLE GUANYLATE CYCLASE ALPHA1 GENE; WILD TYPE;

ANIMALS; CARBACHOL; CYCLIC GMP; DINOPROST; FEMALE; GASTROINTESTINAL MOTILITY; GUANYLATE CYCLASE; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; PYRAZOLES; PYRIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VASOACTIVE INTESTINAL PEPTIDE;

EID: 35648999459     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.140608     Document Type: Article

References (54)

1. Anvari M, Paterson CA & Daniel EE (1998). Role of nitric oxide mechanisms in control of pyloric motility and transpyloric flow of liquids in conscious dogs. Dig Dis Sci 43, 506-512.
2. Bawankule DU, Sathishkumar K, Sardar KK, Chanda D, Krishna AV, Prakash VR & Mishra SK (2005). BAY 41-2272 [5-cyclopropyl-2-]1-(2-fluoro-benzyl) -1H-pyrazolo[3,4-b]pyridine-3-yl[pyri midin-4-ylamine]-induced dilation in ovine pulmonary artery: Role of sodium pump. J Pharmacol Exp Ther 314, 207-213.
3. Bayguinov O & Sanders KM (1998). Dissociation between electrical and mechanical responses to nitrergic stimulation in the canine gastric fundus. J Physiol 509, 437-448.
4. Behrends S (2003). Drugs that activate specific nitric oxide sensitive guanylyl cyclase isoforms independent of nitric oxide release. Curr Med Chem 10, 291-301.
5. 2+ sensitivity by cyclic nucleotides in smooth muscle from protein kinase G-deficient mice. J Biol Chem 279, 5146-5151.
6. D'Amato M, Curro D, Montuschi P, Ciabattoni G, Ragazzoni E & Lefebvre RA (1992). Release of vasoactive intestinal polypeptide from the rat gastric fundus. Br J Pharmacol 105, 691-695.
7. de Rosalmeida MC, da Saraiva LDG Jr, Ivo BB, da Nobrega MV, Gondim FA, Rola FH & dos Santos AA (2003). Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats. Dig Dis Sci 48, 2064-2068.
8. Desai KM, Sessa WC & Vane JR (1991). Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 351, 477-479.
9. Dick JM & Lefebvre RA (1997). Influence of different classes of NO synthase inhibitors in the pig gastric fundus. Naunyn Schmiedebergs Arch Pharmacol 356, 488-494.
10. Dick JM, Van Molle W, Brouckaert P & Lefebvre RA (2002). Relaxation by vasoactive intestinal polypeptide in the gastric fundus of nitric oxide synthase-deficient mice. J Physiol 538, 133-143.
11. Friebe A, Mergia E, Dangel O, Lange A & Koesling D (2007). Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase. Proc Natl Acad Sci U S A 104, 7699-7704.
12. Garcia-Pascual A & Triguero D (1994). Relaxation mechanisms induced by stimulation of nerves and by nitric oxide in sheep urethral muscle. J Physiol 476, 333-347.
13. Groneberg D, Koesling D & Friebe A (2007). Lack of NO-mediated NANC relaxation in mice deficient in NO-sensitive guanylyl cyclase. 3rd International Conference on cGMP, Abstract 24.
14. Harteneck C, Wedel B, Koesling D, Malkewitz J, Bohme E & Schultz G (1991). Molecular cloning and expression of a new α-subunit of soluble guanylyl cyclase. Interchangeability of the α-subunits of the enzyme. FEBS Lett 292, 217-222.
15. Hobbs AJ (1997). Soluble guanylate cyclase: The forgotten sibling. Trends Pharmacol Sci 18, 484-491.
16. Huang PL, Dawson TM, Bredt DS, Snyder SH & Fishman MC (1993). Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75, 1273-1286.
17. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P & Snyder SH (2001). Protein S-nitrosylation: A physiological signal for neuronal nitric oxide. Nat Cell Biol 3, 193-197.
18. Keilbach A, Ruth P & Hofmann F (1992). Detection of cGMP dependent protein kinase isozymes by specific antibodies. Eur J Biochem 208, 467-473.
19. Kelm M & Schrader J (1990). Control of coronary vascular tone by nitric oxide. Circ Res 66, 1561-1575.
20. Koglin M, Stasch JP & Behrends S (2002). BAY 41-2272 activates two isoforms of nitric oxide-sensitive guanylyl cyclase. Biochem Biophys Res Commun 292, 1057-1062.
21. Laburthe M & Couvineau A (2002). Molecular pharmacology and structure of VPAC receptors for VIP and PACAP. Regul Pept 108, 165-173.
22. Lefebvre RA, Baert E & Barbier AJ (1992). Influence of N G -nitro-L-arginine on non-adrenergic non-cholinergic relaxation in the guinea-pig gastric fundus. Br J Pharmacol 106, 173-179.
23. Li CG & Rand MJ (1990). Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur J Pharmacol 191, 303-309.
24. Martins SL, De Oliveira RB & Ballejo G (1995). Rat duodenum nitrergic-induced relaxations are cGMP-independent and apamin-sensitive. Eur J Pharmacol 284, 265-270.
25. Mashimo H, Kjellin A & Goyal RK (2000). Gastric stasis in neuronal nitric oxide synthase-deficient knockout mice. Gastroenterology 119, 766-773.
26. Mergia E, Friebe A, Dangel O, Russwurm M & Koesling D (2006). Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J Clin Invest 116, 1731-1737.
27. Mergia E, Russwurm M, Zoidl G & Koesling D (2003). Major occurrence of the new α2β1 isoform of NO-sensitive guanylyl cyclase in brain. Cell Signal 15, 189-195.
28. Minami H & McCallum RW (1984). The physiology and pathophysiology of gastric emptying in humans. Gastroenterology 86, 1592-1610.
29. 1 subunit in vascular smooth muscle relaxation. Cardiovasc Res (in press; doi:).
30. Ny L, Pfeifer A, Aszodi A, Ahmad M, Alm P, Hedlund P, Fassler R & Andersson KE (2000). Impaired relaxation of stomach smooth muscle in mice lacking cyclic GMP-dependent protein kinase I. Br J Pharmacol 129, 395-401.
31. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R & Hofmann F (1998). Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17, 3045-3051.
32. Pheng LH, Nguyen-Le XK, Nsa AS, Gobeil F & Regoli D (1997). Kinin receptors in the diabetic mouse. Can J Physiol Pharmacol 75, 609-611.
33. Plourde V, Quintero E, Suto G, Coimbra C & Tache Y (1994). Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats. Eur J Pharmacol 256, 125-129.
34. Rand MJ & Li CG (1995). Nitric oxide as a neurotransmitter in peripheral nerves: Nature of transmitter and mechanism of transmission. Annu Rev Physiol 57, 659-682.
35. Russwurm M, Behrends S, Harteneck C & Koesling D (1998). Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem J 335, 125-130.
36. Russwurm M, Wittau N & Koesling D (2001). Guanylyl cyclase/PSD-95 interaction: Targeting of the nitric oxide-sensitive α2β1 guanylyl cyclase to synaptic membranes. J Biol Chem 276, 44647-44652.
37. Sarnelli G, Sifrim D, Janssens J & Tack J (2004). Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol 287, G988-G992.
38. Schlossmann J & Hofmann F (2005). cGMP-dependent protein kinases in drug discovery. Drug Discov Today 10, 627-634.
39. Schmidt HH (1992). NO, CO and OH. Endogenous soluble guanylyl cyclase-activating factors. FEBS Lett 307, 102-107.
40. Schrammel A, Behrends S, Schmidt K, Koesling D & Mayer B (1996). Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 50, 1-5.
41. Selemidis S & Cocks TM (2000). Nitrergic relaxation of the mouse gastric fundus is mediated by cyclic GMP-dependent and ryanodine-sensitive mechanisms. Br J Pharmacol 129, 1315-1322.
42. Shah V, Lyford G, Gores G & Farrugia G (2004). Nitric oxide in gastrointestinal health and disease. Gastroenterology 126, 903-913.
43. Simon B & Kather H (1978). Activation of human adenylate cyclase in the upper gastrointestinal tract by vasoactive intestinal polypeptide. Gastroenterology 74, 722-725.
44. Sips P, Buys E, Rogge E, Dewerchin M & Brouckaert P (2005). Functional knockout of the soluble guanylate cyclase α1 subunit leads to gender-specific hypertension while retaining sensitivity to nitric oxide. Circulation 112, A747 (Abstract).
45. Smits GJ & Lefebvre RA (1996). ATP and nitric oxide: Inhibitory NANC neurotransmitters in the longitudinal muscle-myenteric plexus preparation of the rat ileum. Br J Pharmacol 118, 695-703.
46. Stone JR & Marletta MA (1996). Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry 35, 1093-1099.
47. Sun WM, Doran S, Jones KL, Ooi E, Boeckxstaens G, Hebbard GS, Lingenfelser T, Morley JE, Dent J & Horowitz M (1998). Effects of nitroglycerin on liquid gastric emptying and antropyloroduodenal motility. Am J Physiol Gastrointest Liver Physiol 275, G1173-G1178.
48. Tanaka T, Mizumoto A & Itoh Z (2005). Effects of nitric oxide synthase inhibitor on the digestive system measured by simultaneous monitoring of gastric motility, gastric emptying activity and postprandial pancreaticobiliary secretion in dogs. Exp Anim 54, 309-317.
49. Teixeira CE, Priviero FB & Webb RC (2006). Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-]1-(2-fluorobenzyl)-1H- pyrazolo[3,4-b]pyridin-3-yl[pyrimidin-4-ylamine] and YC-1 [3- (5′-hydroxymethyl-2′-furyl)-1-benzyl Indazole]. J Pharmacol Exp Ther 317, 258-266.
50. Toda N & Herman AG (2005). Gastrointestinal function regulation by nitrergic efferent nerves. Pharmacol Rev 57, 315-338.
51. Ward SM & Sanders KM (2006). Involvement of intramuscular interstitial cells of Cajal in neuroeffector transmission in the gastrointestinal tract. J Physiol 576, 675-682.
52. Watson MJ, Bywater RA, Taylor GS & Lang RJ (1996). Effects of nitric oxide (NO) and NO donors on the membrane conductance of circular smooth muscle cells of the guinea-pig proximal colon. Br J Pharmacol 118, 1605-1614.
53. Xue L, Farrugia G, Miller SM, Ferris CD, Snyder SH & Szurszewski JH (2000). Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: Evidence from genomic deletion of biosynthetic enzymes. Proc Natl Acad Sci U S A 97, 1851-1855.
54. Zabel U, Kleinschnitz C, Oh P, Nedvetsky P, Smolenski A, Muller H, Kronich P, Kugler P, Walter U, Schnitzer JE & Schmidt HH (2002). Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol 4, 307-311.